Results 11 to 20 of about 7,038 (204)

Ophthalmic and anesthetic evaluation of topical 1% tetracaine and 0.5% proparacaine in dogs [PDF]

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2011
The aim of this study was to establish the action of 1% tetracaine eye drops in combination with 0.1% phenylephrine in two different posologies and their effects on the eye compared to the 0.5% proparacaine drops in dogs. 22 animals were divided into two
H.D. Parchen   +6 more
doaj   +2 more sources

The effect of cold tetracaine on the severity of burning sensation upon instillation

open access: yesClinical Ophthalmology, 2018
Wiwan Sansanayudh,1 Thitima Phansucharitthai,1 Nakarin Sansanayudh2 1Ophthalmology Department, Phramongkutklao Hospital, Bangkok, Thailand; 2Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand Purpose: Tetracaine is one of the ...
Sansanayudh W   +2 more
doaj   +1 more source

Cytotoxic effect and possible mechanisms of Tetracaine on human corneal epithelial cells in vitro [PDF]

open access: yesInternational Journal of Ophthalmology, 2016
AIM: To demonstrate the cytotoxic effect and possible mechanisms of Tetracaine on human corneal epithelial (HCEP) cells in vitro. METHODS: In vitro cultured HCEP cell were treated with Tetracaine hydrochloride at different doses for different times, and
Xin Pang, Ting-Jun Fan
doaj   +2 more sources

Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery

open access: yesClinical Ophthalmology, 2010
Anthoula T Tsoumani1,2, Ioannis C Asproudis1, Dimitrios Damigos21Department of Ophthalmology University Hospital of Ioannina, 2Department of Medical Psychology, Postgraduate Course of “Pain Management”, University of Ioannina ...
Anthoula T Tsoumani   +2 more
doaj   +2 more sources

Effect of the buffer system on stability of tetracaine hydrochloride 0.5% eyedrops [PDF]

open access: yesMakedonsko Farmacevtski Bilten, 2002
The effect of the buffer system on the stability of tetracaine hydrochloride in eyedrop formulation was evaluated. Eyedrop formulations containing tetracaine hydrochloride 0.5%(w/v) were prepared using different buffer systems (acetate, phosphate and ...
Emilija Fredro-Kumbaradzi   +4 more
doaj   +1 more source

Comparative analyses of response surface methodology and artificial neural networks on incorporating tetracaine into liposomes

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2020
This study evaluated the incorporation of tetracaine into liposomes by RSM (Response Surface Methodology) and ANN (Artificial Neural Networks) based models.
Ana Karina Vidal Pereira   +4 more
doaj   +3 more sources

The effects and side effects of lidocaine tetracaine peel off on laser-assisted hair removal

open access: yesAdvanced Biomedical Research, 2014
Background: Lidocaine 7%-tetracaine 7% is one of the combinations recently offered for performing laser-assisted hair removal. The aim of this study was to compare the effects of this combination with placebo on the side effects of laser-assisted hair ...
Ali Asilian   +3 more
doaj   +2 more sources

Effect of Tetracaine on Intraocular Pressure in Normal and Hypertensive Rabbit Eyes

open access: yesJournal of Ophthalmic & Vision Research, 2012
Purpose: To evaluate the effect of tetracaine on intraocular pressure (IOP) in normal and hypertensive rabbit eyes. Methods: The study was conducted on 12 healthy rabbits as controls and 6 healthy rabbits in which an experimental model of ocular ...
Ali Asghar Sarchahi, Hooman Bozorgi
doaj   +1 more source

Effects of Preemptive Eye Drops Ketorolac plus Tetracaine on Pain Intensity and Hemodynamic Changes in Cataract Surgery [PDF]

open access: yesMajallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2017
Background: The aim of this study is to evaluate the impact of preemptive adding topical Ketorolac to Tetracaine drop on pain intensity and hemodynamic parameters during and after cataract surgery.
Mojtaba Rahimi Varposhti   +4 more
doaj   +1 more source

Virtual Screening and Zebrafish Phenotype-Based Evaluation Argues Against Repurposing 4-Phenylbutyrate for STXBP1-Related Disorders. [PDF]

open access: yesPharmacol Res Perspect
ABSTRACT Syntaxin‐binding protein 1 (STXBP1) mutations lead to severe epilepsy, intellectual disability, developmental delay, and movement disorder. Effective treatments for these conditions do not exist. Recent studies in Munc18‐1 (STXBP1) C. elegans models demonstrate that 4‐phenylbutyrate (4‐PBA) or related pharmacological chaperones stabilize ...
Frick A, Whyte-Fagundes P, Baraban SC.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy